Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 111 shares at $28.03 ($3K) on 2021-11-04, disclosed to the SEC on 2021-11-08.
Scheduled sale ($3k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.03 | 100 | $3K | 90.1% |
| 2 | $28.11 | 11 | $309 | 9.9% |
| Total | $28.04 avg | 111 | $3K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |